-
Public health is a familiar setting for many readers of Contraceptive Technology Update. About 51% of respondents to the 2012 Salary Survey say they work in a health department, and most noted no changes in 2012 staffing numbers.
-
Emergency contraception (EC) should be widely available and easily accessible to all women, according to a just-released committee opinion issued by the American College of Obstetricians and Gynecologists (ACOG).
-
In 1992, reproductive health advocates estimated that widespread use of emergency contraceptive pills (ECPs) could prevent half of all U.S. unintended pregnancies and abortions.
-
-
-
Pre-exposure prophylaxis (PrEP) for HIV prevention has taken a giant step forward with a Food and Drug Administration (FDA) committee's recommendation for approval of a specific drug for such use.
-
Look for new labeling on combined oral contraceptives (OCs) containing drospirenone following the Food and Drug Administration's (FDA) review of studies regarding the risk of blood clots in women using such formulations.
-
As of this writing, in mid-May, policymaking at the federal level was at a standstill, with lawmakers waiting on two major events: the Supreme Court's June decision on the Affordable Care Act and the November national elections. So, for this month's column, we'll turn our attention to the state level, where policymakers are having another busy year.
-
Results from a multi-country clinical trial of a combined oral contraceptive (OC) containing nomegestrol acetate and 17-beta estradiol indicate it is an effective pill with good cycle control.
-
Family planning clinicians are familiar with the injectable contraceptive depot medroxyprogesterone acetate (DMPA) as an effective form of reversible birth control, following only the contraceptive implant and intrauterine device (IUD) in contraceptive efficacy.